Jubilant Pharmova Limited · NSE: JUBLPHARMA · BSE: 530019
Jubilant Pharmova
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 10 Aug 2026.
Q1 FY27 · Consolidated
Revenue
2,229.40₹ Cr
+17.3% vs year ago
Net profit
56.40₹ Cr
−45.0% vs year ago
EPS, basic
3.57₹
−45.0% vs year ago
Net margin
2.5%
−2.9 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 2,229.40 | +17.3% | 56.40 | −45.0% | 3.57 | 10 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 2,290.00 | +18.7% | 119.30 | −21.2% | 7.55 | 22 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2,122.50 | +16.5% | 55.80 | −44.6% | 3.52 | 06 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 1,966.40 | +12.2% | 119.90 | +17.0% | 7.59 | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 1,900.70 | +9.8% | 102.50 | −78.7% | 6.49 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 1,928.80 | +996.8% | 151.30 | Turned profit | 9.71 | 16 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1,821.70 | +8.6% | 100.70 | +51.7% | 6.37 | 31 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,752.30 | +4.3% | 102.50 | +65.1% | 6.47 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1,731.70 | +9.1% | 481.80 | 80x | 30.44 | 20 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 175.86 | −89.5% | (6.18) | Loss narrowed | (3.69) | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 1,677.10 | +8.0% | 66.40 | Turned profit | 4.22 | 03 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,680.30 | +5.1% | 62.10 | 13x | 3.94 | 30 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 1,586.90 | +10.2% | 6.00 | −87.2% | 0.40 | 20 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 1,678.00 | +10.8% | (100.51) | Turned loss | (6.15) | 30 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,552.51 | +18.5% | (16.04) | Turned loss | (0.98) | 06 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,599.50 | −3.5% | 4.92 | −96.6% | 0.34 | 24 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 1,440.47 | −11.9% | 46.75 | −70.9% | 2.96 | 02 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 1,514.44 | −4.1% | 59.09 | −72.3% | 3.74 | 28 May 2022 |
| Q3 FY22Oct–Dec 2021 | 1,310.53 | −26.0% | 50.80 | −83.6% | 3.20 | 04 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 1,657.45 | −30.2% | 142.64 | −36.4% | 8.97 | 22 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 1,634.65 | −13.6% | 160.49 | +82.4% | 10.09 | 23 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 1,579.78 | −33.9% | 213.65 | −18.0% | 13.43 | 05 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 1,771.34 | −23.5% | 309.83 | +52.3% | 19.46 | 06 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 2,374.89 | +4.8% | 224.12 | −10.1% | 14.06 | 06 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 1,892.92 | −13.2% | 88.01 | −52.4% | 5.53 | 04 Sep 2020 |
| Q4 FY20Jan–Mar 2020 | 2,391.41 | +0.2% | 260.49 | Turned profit | 16.35 | 30 May 2020 |
| Q3 FY20Oct–Dec 2019 | 2,315.21 | −2.6% | 203.38 | −24.0% | 12.77 | 31 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 2,265.93 | −0.2% | 249.39 | +18.9% | 15.66 | 26 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 2,181.86 | +5.0% | 184.98 | −7.7% | 11.61 | 26 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 2,385.58 | — | (100.65) | — | (6.38) | 18 May 2019 |
| Q3 FY19Oct–Dec 2018 | 2,377.10 | — | 267.52 | — | 16.74 | 01 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 2,269.49 | — | 209.77 | — | 13.50 | 23 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 2,078.65 | — | 200.37 | — | 13.00 | 30 Jul 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 67.10 | +12.8% | 7.30 | +25.9% | 0.46 | 10 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 70.30 | −67.6% | 57.20 | +320.6% | 3.59 | 22 May 2026 |
| Q3 FY26Oct–Dec 2025 | 67.30 | −65.7% | 6.60 | +24.5% | 0.42 | 06 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 66.40 | −59.9% | (6.40) | Turned loss | (0.40) | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 59.50 | −64.3% | 5.80 | Turned profit | 0.36 | 29 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 217.30 | +5.6% | 13.60 | −58.2% | 0.86 | 16 May 2025 |
| Q3 FY25Oct–Dec 2024 | 196.00 | +11.9% | 5.30 | Turned profit | 0.33 | 31 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 165.70 | −11.1% | 10.50 | Turned profit | 0.66 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 166.70 | −23.3% | (10.20) | Turned loss | (0.64) | 20 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 205.80 | +3.0% | 32.50 | Turned profit | 2.05 | 01 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 175.20 | −4.1% | (2.40) | Loss narrowed | (0.15) | 03 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 186.30 | −16.4% | (0.40) | Turned loss | (0.03) | 30 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 217.40 | +8.7% | 1.90 | Turned profit | 0.12 | 20 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 199.84 | +594.1% | (30.86) | Loss widened | (1.94) | 30 May 2023 |
| Q3 FY23Oct–Dec 2022 | 182.74 | +878.8% | (5.89) | Loss widened | (0.37) | 06 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 222.97 | 11x | 91.81 | +4.2% | 5.77 | 24 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 200.04 | +887.4% | (5.18) | Loss widened | (0.33) | 02 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 28.79 | −92.1% | (3.11) | Turned loss | (0.19) | 28 May 2022 |
| Q3 FY22Oct–Dec 2021 | 18.67 | −97.7% | (5.34) | Turned loss | (0.34) | 04 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 20.03 | −97.4% | 88.08 | +40.6% | 5.53 | 22 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 20.26 | −97.3% | (1.13) | Turned loss | 0.07 | 23 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 365.86 | −53.8% | 35.16 | −68.4% | 2.21 | 05 Jun 2021 |
| Q3 FY21Oct–Dec 2020 | 828.94 | +3.5% | 64.65 | +86.7% | 4.06 | 06 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 760.75 | +0.4% | 62.63 | −56.2% | 3.93 | 06 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 753.95 | −4.5% | 52.04 | +61.3% | 3.27 | 04 Sep 2020 |
| Q4 FY20Jan–Mar 2020 | 791.36 | −8.5% | 111.18 | 15x | 6.98 | 30 May 2020 |
| Q3 FY20Oct–Dec 2019 | 801.18 | −6.8% | 34.63 | −5.6% | 2.17 | 31 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 757.54 | −14.6% | 143.07 | +79.7% | 8.98 | 26 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 789.82 | −4.5% | 32.26 | +35.1% | 2.03 | 26 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 865.12 | — | 7.44 | — | 0.47 | 18 May 2019 |
| Q3 FY19Oct–Dec 2018 | 859.58 | — | 36.70 | — | 2.30 | 01 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 887.27 | — | 79.61 | — | 5.00 | 23 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 826.64 | — | 23.88 | — | 1.50 | 30 Jul 2018 |
66 filings on record for this company.